ArticleJHEP reports : innovation in hepatology2023

HBV001: Phase I study evaluating the safety and immunogenicity of the therapeutic vaccine ChAdOx1-HBV.

Tamsin Cargill et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.